{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:37:38Z","timestamp":1740145058715,"version":"3.37.3"},"reference-count":27,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"Robert Wood Johnson Foundation Physician Faculty-Scholar\u2018s"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["1K23AI095357-01"],"award-info":[{"award-number":["1K23AI095357-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.2217\/fmb.12.44","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T15:44:00Z","timestamp":1340034240000},"page":"677-683","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Fidaxomicin Compared with Oral Vancomycin for the Treatment of Adults with\n            <i>Clostridium difficile<\/i>\n            -Associated Diarrhea: Data from the OPT-80-003 and OPT-80-004 Studies"],"prefix":"10.1080","volume":"7","author":[{"given":"Luke F","family":"Chen","sequence":"first","affiliation":[{"name":"Program for Infection Prevention &amp; Healthcare Epidemiology, Duke University Medical Center, Durham, NC27710, USA"},{"name":"Antimicrobial Stewardship &amp; Evaluation Team, Duke University Medical Center, Durham, NC27710, USA"},{"name":"Duke Infection Control Outreach Network (DICON), Division of Infectious Diseases &amp; International Health, Department of Medicine, Duke University Medical Center, Durham, NC27710, USA"},{"name":"Duke University Prevention Epicenter Program, Duke University Medical Center, Durham, NC27710, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deverick J","family":"Anderson","sequence":"additional","affiliation":[{"name":"Program for Infection Prevention &amp; Healthcare Epidemiology, Duke University Medical Center, Durham, NC27710, USA"},{"name":"Antimicrobial Stewardship &amp; Evaluation Team, Duke University Medical Center, Durham, NC27710, USA"},{"name":"Duke Infection Control Outreach Network (DICON), Division of Infectious Diseases &amp; International Health, Department of Medicine, Duke University Medical Center, Durham, NC27710, USA"},{"name":"Duke University Prevention Epicenter Program, Duke University Medical Center, Durham, NC27710, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,6,18]]},"reference":[{"key":"e_1_3_2_2_1_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00445-10"},{"key":"e_1_3_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051639"},{"key":"e_1_3_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05053-11"},{"key":"e_1_3_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051590"},{"issue":"1","key":"e_1_3_2_2_5_1","first-page":"E070111","volume":"12","author":"Kato H","year":"2007","unstructured":"Kato H , ItoY, van den Berg RJ, Kuijper EJ, Arakawa Y. First isolation of Clostridium difficile 027 in Japan. Euro. Surveill.12(1) , E070111\u2013E070113 (2007).","journal-title":"Euro. Surveill."},{"key":"e_1_3_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/658333"},{"key":"e_1_3_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70080-3"},{"key":"e_1_3_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0707500"},{"key":"e_1_3_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1406.071447"},{"key":"e_1_3_2_2_10_1","unstructured":"Elixhauser A JhungM. Clostridium difficile-associated disease in U.S. Hospitals 1993\u20132005: statistical brief #50. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Health Care Policy and Research Rockville MD USA (2006)."},{"key":"e_1_3_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-010-0025-0"},{"key":"e_1_3_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/659156"},{"key":"e_1_3_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/651706"},{"key":"e_1_3_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01443-07"},{"key":"e_1_3_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4898-4902.2004"},{"key":"e_1_3_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00090-10"},{"key":"e_1_3_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2009.09.005"},{"key":"e_1_3_2_2_18_1","unstructured":"US Food and Drug Administration. Anti-Infective Drug Advisory Committee Meeting Briefing Document April 5 2011. US Food and Drug Administration Silver Spring MD USA (2011)."},{"key":"e_1_3_2_2_19_1","unstructured":"US Food and Drug Administration. NDA Approval for Fidaxomicin. 2011(11\/28). US Food and Drug Administration Silver Spring MD USA (2010)."},{"key":"e_1_3_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/430311"},{"key":"e_1_3_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/430315"},{"key":"e_1_3_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00104-11"},{"key":"e_1_3_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910812"},{"key":"e_1_3_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70374-7"},{"key":"e_1_3_2_2_25_1","unstructured":"US Food and Drug Administration. Guidance for Industry Non-Inferiority Clinical Trials. US Food and Drug Administration Silver Spring MD USA (2010)."},{"key":"e_1_3_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.07.011"},{"key":"e_1_3_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir404"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.12.44","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:39:48Z","timestamp":1719124788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.12.44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.2217\/fmb.12.44"],"URL":"https:\/\/doi.org\/10.2217\/fmb.12.44","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"type":"print","value":"1746-0913"},{"type":"electronic","value":"1746-0921"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}